End-of-day quote
Shanghai S.E.
06:00:00 2024-06-03 pm EDT
|
5-day change
|
1st Jan Change
|
1.63
CNY
|
-5.23%
|
|
-5.78%
|
-51.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,335
|
2,651
|
5,020
|
9,198
|
4,630
|
2,315
|
Enterprise Value (EV)
1 |
3,711
|
3,586
|
6,330
|
10,597
|
6,008
|
3,988
|
P/E ratio
|
348
x
|
-58.6
x
|
236
x
|
-395
x
|
-32.7
x
|
-4.97
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.04
x
|
9.97
x
|
42.1
x
|
47.8
x
|
6.8
x
|
8.1
x
|
EV / Revenue
|
6.72
x
|
13.5
x
|
53.1
x
|
55.1
x
|
8.82
x
|
14
x
|
EV / EBITDA
|
328
x
|
-101
x
|
-1,035
x
|
-665
x
|
171
x
|
-60.9
x
|
EV / FCF
|
109
x
|
-7.01
x
|
-16.5
x
|
181
x
|
28.4
x
|
-88.6
x
|
FCF Yield
|
0.92%
|
-14.3%
|
-6.07%
|
0.55%
|
3.52%
|
-1.13%
|
Price to Book
|
3.83
x
|
2.95
x
|
5.25
x
|
10.1
x
|
7.36
x
|
13.8
x
|
Nbr of stocks (in thousands)
|
684,884
|
684,884
|
684,884
|
684,884
|
684,884
|
684,884
|
Reference price
2 |
4.870
|
3.870
|
7.330
|
13.43
|
6.760
|
3.380
|
Announcement Date
|
4/25/19
|
4/22/20
|
4/26/21
|
4/26/22
|
4/27/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
552.1
|
265.8
|
119.1
|
192.4
|
681.1
|
285.7
|
EBITDA
1 |
11.31
|
-35.52
|
-6.118
|
-15.93
|
35.11
|
-65.48
|
EBIT
1 |
-2.82
|
-50.75
|
-20.52
|
-41.65
|
-87.37
|
-203
|
Operating Margin
|
-0.51%
|
-19.1%
|
-17.23%
|
-21.65%
|
-12.83%
|
-71.04%
|
Earnings before Tax (EBT)
1 |
11.95
|
-55.87
|
20.07
|
-28.51
|
-165.8
|
-516.4
|
Net income
1 |
9.401
|
-44.95
|
20.91
|
-22.96
|
-141.5
|
-465.5
|
Net margin
|
1.7%
|
-16.91%
|
17.55%
|
-11.94%
|
-20.77%
|
-162.94%
|
EPS
2 |
0.0140
|
-0.0660
|
0.0310
|
-0.0340
|
-0.2070
|
-0.6800
|
Free Cash Flow
1 |
34.05
|
-511.8
|
-384.6
|
58.7
|
211.3
|
-45
|
FCF margin
|
6.17%
|
-192.59%
|
-322.85%
|
30.51%
|
31.02%
|
-15.75%
|
FCF Conversion (EBITDA)
|
301.05%
|
-
|
-
|
-
|
601.7%
|
-
|
FCF Conversion (Net income)
|
362.21%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/19
|
4/22/20
|
4/26/21
|
4/26/22
|
4/27/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
376
|
936
|
1,310
|
1,399
|
1,379
|
1,673
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
33.24
x
|
-26.35
x
|
-214.2
x
|
-87.78
x
|
39.26
x
|
-25.55
x
|
Free Cash Flow
1 |
34.1
|
-512
|
-385
|
58.7
|
211
|
-45
|
ROE (net income / shareholders' equity)
|
1.15%
|
-5.43%
|
2.11%
|
-2.4%
|
-17.4%
|
-80.9%
|
ROA (Net income/ Total Assets)
|
-0.08%
|
-1.43%
|
-0.46%
|
-0.77%
|
-1.66%
|
-4.07%
|
Assets
1 |
-11,960
|
3,138
|
-4,550
|
3,000
|
8,530
|
11,443
|
Book Value Per Share
2 |
1.270
|
1.310
|
1.400
|
1.330
|
0.9200
|
0.2500
|
Cash Flow per Share
2 |
0.1100
|
0.2500
|
0.3000
|
0.1600
|
0.1300
|
0.0400
|
Capex
1 |
73.5
|
499
|
733
|
251
|
59.3
|
57.7
|
Capex / Sales
|
13.31%
|
187.87%
|
615.29%
|
130.23%
|
8.71%
|
20.19%
|
Announcement Date
|
4/25/19
|
4/22/20
|
4/26/21
|
4/26/22
|
4/27/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -51.78% | 163M | | +3.49% | 104B | | -8.98% | 62.15B | | +82.86% | 49.04B | | +14.68% | 37.81B | | -0.68% | 31.1B | | +10.20% | 20.14B | | +10.56% | 16.52B | | +7.90% | 13.85B | | -2.61% | 13.11B |
Other Commodity Chemicals
|